Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 31, 2025

(NASDAQ:NDAQ), NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) — At the end of the settlement date of July 31, 2025, short interest in 3,285 Nasdaq Global MarketSM securities totaled 13,683,072,188 shares compared with 13,792,841,090 shares in 3,260 Global Market issues reported for the prior settlement date of July 15, 2025. The mid-July short interest represents […]

HF Foods Reports Second Quarter 2025 Financial Results

(NASDAQ:HFFG), LAS VEGAS, Aug. 11, 2025 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods” or the “Company”), a leading distributor of international foodservice solutions to Asian restaurants and other businesses across the United States, reported its unaudited financial results for the quarter ended June 30, 2025. Second Quarter 2025 Financial Results Net

BioVie Inc. Announces Closing of $12 Million Public Offering

BioVie Inc. Announces Closing of $12 Million Public Offering GlobeNewswire August 11, 2025 CARSON CITY, Nev., Aug. 11, 2025 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI, BIVIW), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders, today announced the closing

Hallador Energy Company Reports Second Quarter 2025 Financial and Operating Results

Hallador Energy Company Reports Second Quarter 2025 Financial and Operating Results GlobeNewswire August 11, 2025 – Q2 Total Revenue up 10% YoY to $102.9 Million –– Q2 Net Income Increases to $8.2 Million or $0.19 Earnings per Share –– Q2 Operating Cash Flow of $11.4 Million –– Q2 Adjusted EBITDA increases to $3.4 Million –

Exodus Reports Second Quarter 2025 Results

(NYSE MKT:EXOD), OMAHA, Neb., Aug. 11, 2025 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus”), a leading self-custodial cryptocurrency platform, today announced its unaudited results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights (Unaudited) In USD millions, except percentages Q2 2025 Q2 2024 % Change Revenue $ 25.8

Synchronoss Technologies Reports Second Quarter 2025 Results

Synchronoss Technologies Reports Second Quarter 2025 Results GlobeNewswire August 11, 2025 Second Quarter Revenue of $42.5 Million, Including 92.6% Recurring Revenue Received CARES Act Tax Refund in Full, Amounting to $33.9 Million Reaffirms All Full Year Guidance Metrics BRIDGEWATER, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) — Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR),

Lightbridge Provides Business Update and Announces Second Quarter 2025 Financial Results

(NASDAQ:LTBR), RESTON, Va., Aug. 11, 2025 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the second quarter ended June 30, 2025, and provided an update on the Company's continued progress. Seth Grae, President & Chief Executive Officer of Lightbridge Corporation, commented,

Gaia Reports Second Quarter 2025 Results

(NasdaqGM:GAIA), BOULDER, Colo., Aug. 11, 2025 (GLOBE NEWSWIRE) — Gaia, Inc. (NASDAQ: GAIA), a conscious media and community company, reported financial results for the second quarter ended June 30, 2025. Highlights: Gross profit increased 16% and revenue increased 12%, compared to Q2 of the prior year, which represents the sixth consecutive quarter of double digit

ACV Announces Second Quarter 2025 Results

ACV Announces Second Quarter 2025 Results Delivered Record Revenue and Adjusted EBITDA GlobeNewswire August 11, 2025 Second quarter revenue of $194 million Second quarter GAAP net income (loss) of ($7) million Second quarter non-GAAP net income of $12 million Second quarter Adjusted EBITDA of $19 million Expects 2025 revenue of $765 million to $775 million,

IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch

(NasdaqGM:IMDX), Reiterating timelines for FDA submission in 2025 Transplant clinical trial has attracted leading transplant hospitals Booked first revenue from first-generation GraftAssureIQ research-use-only kits; began shipping second generation kits in June NASHVILLE, Tenn., Aug. 11, 2025 (GLOBE NEWSWIRE) — Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today published the following letter to shareholders in

Scroll to Top